Sugi Predict

Sugi Predict / Compounds / SCHEMBL30159330

SCHEMBL30159330

SCHEMBL30159330

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.79

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 4/20 0.73
▸ GLP1R P43220 12/20 0.71
▸ NPY1R P25929 1/20 0.70
▸ NPY2R P49146 1/20 0.70
▸ NPY4R P50391 1/20 0.70
▸ NPY5R Q15761 1/20 0.70
▸ GCGR P47871 5/20 0.69
▸ CCKBR P32239 4/20 0.68
▸ KEAP1 Q14145 1/20 0.66
▸ GIPR P48546 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30658237 0.96 CALCR (0.76) CALCRGLP1RNPY1RNPY2RNPY4R
SCHEMBL30721546 0.96 CALCR (0.73) CALCRGLP1RNPY1RNPY2RNPY4R
SCHEMBL30721590 0.96 CALCR (0.73) CALCRGLP1RNPY1RNPY2RNPY4R
SCHEMBL30721581 0.95 CALCR (0.74) CALCRGLP1RNPY1RNPY2RNPY4R
SCHEMBL30721565 0.95 CALCR (0.74) CALCRGLP1RNPY1RNPY2RNPY4R
SCHEMBL30658311 0.95 CALCR (0.67) CALCRGLP1RNPY1RNPY2RNPY4R
SCHEMBL30721607 0.95 CALCR (0.74) CALCRGLP1RNPY1RNPY2RNPY4R
SCHEMBL30771981 0.95 CALCR (0.77) CALCRGLP1RNPY1RNPY2RNPY4R
SCHEMBL30721556 0.95 CALCR (0.74) CALCRGLP1RNPY1RNPY2RNPY4R
SCHEMBL30932077 0.94 CALCR (0.76) CALCRGLP1RNPY1RNPY2RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260071353-A1 SUBSTRATES, PEPTIDE ARRAYS, AND METHODS VIBRANT HOLDINGS LLC (US) 2026-03-12 — — US disclosed
US-12454771-B2 Substrates, peptide arrays, and methods VIBRANT HOLDINGS LLC (US) 2025-10-28 — — US disclosed
US-20230294063-A1 SUBSTRATES, PEPTIDE ARRAYS, AND METHODS VIBRANT HOLDINGS, LLC 2023-09-21 — — US disclosed
US-11565231-B2 Substrates, peptide arrays, and methods VIBRANT HOLDINGS, LLC (US) 2023-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230294063-A1 SUBSTRATES, PEPTIDE ARRAYS, AND METHODS VIP, IAPP, GIPR CALCR 442/4885GLP1R 43/4885NPY1R 60/4885
US-20260071353-A1 SUBSTRATES, PEPTIDE ARRAYS, AND METHODS VIP, CALCB, SPPL2B CALCR 112/4885GLP1R 23/4885NPY1R 71/4885
US-11565231-B2 Substrates, peptide arrays, and methods VIP, IAPP, GIPR CALCR 442/4885GLP1R 43/4885NPY1R 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback